Nomeda Aleksandra Girnius, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| JNK Mitogen-Activated Protein Kinases | 4 | 2018 | 440 | 1.660 |
Why?
|
| Snake Venoms | 1 | 2024 | 40 | 0.960 |
Why?
|
| Mammary Glands, Animal | 5 | 2023 | 273 | 0.940 |
Why?
|
| Anoikis | 2 | 2017 | 49 | 0.680 |
Why?
|
| MAP Kinase Signaling System | 4 | 2018 | 1494 | 0.580 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 213 | 0.480 |
Why?
|
| Epithelial Cells | 6 | 2023 | 3703 | 0.460 |
Why?
|
| Genomic Instability | 1 | 2018 | 716 | 0.450 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 693 | 0.410 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 979 | 0.340 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1966 | 0.330 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 5341 | 0.330 |
Why?
|
| Leukemia | 1 | 2016 | 1519 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 3 | 2018 | 29 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2018 | 71 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2892 | 0.250 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2024 | 24 | 0.240 |
Why?
|
| Haploinsufficiency | 1 | 2024 | 334 | 0.200 |
Why?
|
| Glutathione | 1 | 2024 | 589 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 381 | 0.190 |
Why?
|
| Integrins | 1 | 2024 | 842 | 0.170 |
Why?
|
| Cues | 1 | 2023 | 878 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13676 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 1155 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2018 | 144 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 8647 | 0.140 |
Why?
|
| Cathepsins | 1 | 2018 | 243 | 0.140 |
Why?
|
| Triglycerides | 1 | 2024 | 2464 | 0.130 |
Why?
|
| Transcription Factor AP-1 | 1 | 2018 | 321 | 0.130 |
Why?
|
| Lactation | 1 | 2018 | 392 | 0.130 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 393 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2018 | 23645 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 22379 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 874 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 18349 | 0.110 |
Why?
|
| Adherens Junctions | 1 | 2013 | 90 | 0.100 |
Why?
|
| Animals | 14 | 2024 | 169246 | 0.100 |
Why?
|
| Apoptosis | 2 | 2019 | 9523 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 1151 | 0.100 |
Why?
|
| Amino Acids | 1 | 2018 | 1716 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1377 | 0.100 |
Why?
|
| Mice | 11 | 2024 | 82029 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2011 | 29 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 3833 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2024 | 14488 | 0.090 |
Why?
|
| Autophagy | 1 | 2018 | 1349 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1351 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17140 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 506 | 0.080 |
Why?
|
| Liver | 1 | 2024 | 7577 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5777 | 0.080 |
Why?
|
| Morphogenesis | 1 | 2011 | 746 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10474 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 21206 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4648 | 0.060 |
Why?
|
| Female | 8 | 2024 | 397192 | 0.060 |
Why?
|
| Cell Line | 1 | 2017 | 15597 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2024 | 217 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1767 | 0.050 |
Why?
|
| Phenotype | 1 | 2018 | 16726 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 2846 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10873 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 53 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1757 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 2227 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 768166 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2019 | 176 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2018 | 185 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1885 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 662 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 1904 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2720 | 0.030 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2019 | 1096 | 0.030 |
Why?
|
| Breast | 1 | 2022 | 1976 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 1058 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 3139 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2981 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 3590 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5446 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2011 | 20 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2011 | 20 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2011 | 44 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2018 | 1247 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 381 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 19015 | 0.020 |
Why?
|
| Epidermis | 1 | 2013 | 539 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6231 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2062 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2013 | 876 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3912 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9561 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7598 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3348 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3623 | 0.020 |
Why?
|
| Male | 2 | 2024 | 364719 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2013 | 8317 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11928 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 30256 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5210 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 223646 | 0.000 |
Why?
|